IL172699A0 - Novel fusidic acid derivatives - Google Patents

Novel fusidic acid derivatives

Info

Publication number
IL172699A0
IL172699A0 IL172699A IL17269905A IL172699A0 IL 172699 A0 IL172699 A0 IL 172699A0 IL 172699 A IL172699 A IL 172699A IL 17269905 A IL17269905 A IL 17269905A IL 172699 A0 IL172699 A0 IL 172699A0
Authority
IL
Israel
Prior art keywords
acid derivatives
fusidic acid
novel
novel fusidic
derivatives
Prior art date
Application number
IL172699A
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2004/000491 external-priority patent/WO2005007669A1/en
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of IL172699A0 publication Critical patent/IL172699A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/002Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 13 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL172699A 2003-07-16 2005-12-20 Novel fusidic acid derivatives IL172699A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200301080 2003-07-16
US48760903P 2003-07-17 2003-07-17
DKPA200301486 2003-10-09
PCT/DK2004/000491 WO2005007669A1 (en) 2003-07-16 2004-07-09 Novel fusidic acid derivatives

Publications (1)

Publication Number Publication Date
IL172699A0 true IL172699A0 (en) 2006-04-10

Family

ID=34084106

Family Applications (1)

Application Number Title Priority Date Filing Date
IL172699A IL172699A0 (en) 2003-07-16 2005-12-20 Novel fusidic acid derivatives

Country Status (6)

Country Link
KR (1) KR20060091290A (en)
IL (1) IL172699A0 (en)
IS (1) IS8301A (en)
MX (1) MXPA06000423A (en)
NO (1) NO20060614L (en)
TW (1) TW200510447A (en)

Also Published As

Publication number Publication date
IS8301A (en) 2006-02-14
TW200510447A (en) 2005-03-16
MXPA06000423A (en) 2006-04-05
NO20060614L (en) 2006-02-08
KR20060091290A (en) 2006-08-18

Similar Documents

Publication Publication Date Title
AU2004266485A1 (en) Phenoxiacetic acid derivatives
IL169905A0 (en) Novel 2-pyridinecarboxamide derivatives
HK1088326A1 (en) Piperidine-benzenesulfonamide derivatives
AU2003232122A8 (en) Ctp-extended erythropoietin
AP2005003343A0 (en) Substituted pyrrolo-pyrazole derivatives as kinaseinhibitors
HK1089443A1 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
GB0317665D0 (en) Qinazoline derivatives
PT1682493E (en) Amidoacetonitrile derivatives
IL175189A0 (en) N-thiazol-2-yl-benzamide derivatives
IL177204A0 (en) Novel 4-benzimidazol -2-ylpyridazin -3- one derivatives
TWI368482B (en) New 2-pyridinylethylbenzamide derivatives
GB0319874D0 (en) Novel formulation
ZA200603778B (en) Novel oxy-nitriles
AU2003303648A1 (en) Novel 5-hydroxyindole-3-carboxylate derivatives
PL1706373T3 (en) Amidoacetonitrile derivatives
IL175678A0 (en) Novel piperidine-substituted indoles-or heteroderivatives thereof
GB0312368D0 (en) Novel ureido- and amido-pyrazolone derivatives
GB0319793D0 (en) Pyridinylmorpholine derivatives
IL172699A0 (en) Novel fusidic acid derivatives
AU2002366980A1 (en) Halogenobenzyl aminopropionic acid derivatives
AU2824P (en) P000603 Plectranthus hilliardiae x Plectranthus saccatus
TWI341309B (en) Heteroarylcarbamoylbenzene derivatives
AU2822P (en) Edelblau Plectranthus saccatus x Plectranthus hilliardiae
GB0316914D0 (en) Novel benzoxazocines
GB0319148D0 (en) Azaquinazoline derivatives